Literature DB >> 1788549

Microangiopathy with retinopathy, encephalopathy, and deafness (RED-M) and systemic features.

M W Nicolle1, R S McLachlan.   

Abstract

The case of a young woman with a rare syndrome of acute encephalopathy followed by deafness and retinopathy developing over 1 year is reported. Unlike previously described similar cases, she had considerable systemic symptoms and signs including polyarthralgia-arthritis, diffuse myalgia, malar rash, livedo reticularis, night sweats, and fatigue suggestive of systemic lupus erythematosus. However, results of most immunological investigations were repeatedly normal, including antinuclear antibodies. Anticardiolipin antibodies were elevated on one occasion. Cyclophosphamide has been the most effective treatment for exacerbations of the disease, which have continued to occur over 6 years. This microangiopathic syndrome more likely relates to an immunologically mediated vasculitis of small blood vessels than to a thromboembolic etiology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788549     DOI: 10.1016/0049-0172(91)90001-g

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  6 in total

1.  Encephalopathy, hearing loss and retinal occlusions (Susac's syndrome): a new case.

Authors:  M Maddestra; S Sabatini; A Paci
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  Susac syndrome: report of four cases and review of the literature.

Authors:  Tai Hung Do; Christiane Fisch; François Evoy
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

Review 3.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

4.  Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome.

Authors:  Jan Dörr; Helena Radbruch; Markus Bock; Jens Wuerfel; Anne Brüggemann; Klaus P Wandinger; Daniel Zeise; Caspar F Pfueller; Frauke Zipp; Friedemann Paul
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

5.  Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis.

Authors:  Vicktoria Vishnevskia-Dai; Joav Chapman; Roee Sheinfeld; Tal Sharon; Ruth Huna-Baron; Riri S Manor; Yehuda Shoenfeld; Ofira Zloto
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model.

Authors:  Robert M Rennebohm; Martin Lubow; Jerome Rusin; Lisa Martin; Deborah M Grzybowski; John O Susac
Journal:  Pediatr Rheumatol Online J       Date:  2008-01-29       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.